Compound information
- Natural Products
- ZC1497600
- Molecular Formula
- C18H28N2O4
- Molecular Weight
- 336.204907376 g/mol
- Structure
-
- IUPAC Name
- tert-butyl (2S)-6-amino-2-(benzyloxycarbonylamino)hexanoate
- InChI
- InChI=1S/C18H28N2O4/c1-18(2,3)24-16(21)15(11-7-8-12-19)20-17(22)23-13-14-9-5-4-6-10-14/h4-6,9-10,15H,7-8,11-13,19H2,1-3H3,(H,20,22)/t15-/m0/s1
- InChI Key
- WSJKYVHGUCIGPN-HNNXBMFYSA-N
- SMILES
- CC(C)(C)OC(=O)[C@H](CCCCN)NC(=O)OCc1ccccc1
- Source
- ZINC000002510597
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 24 | Ring Count | 1 |
Heteroatom Count | 6 | Rotatable Bond Count | 8 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 90.65 Å2 | LogP | 3.014 |
LogS | -2.623 | LogD | 2.59 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.641 | Pgp substrate | 0.024 |
HIA | 0.963 | F20 % | 0.903 |
F30 % | 0.306 | Caco-2 | -4.962 |
MDCK | -4.923 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.981 | PPB | 58.045 |
VD | 1.197 | Fu | 0.667 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.54 | CYP1A2 substrate | 0.581 |
CYP2A6 substrate | 0.496 | CYP2B6 substrate | 0.622 |
CYP2C19 inhibitor | 0.464 | CYP2C19 substrate | 0.865 |
CYP2C8 substrate | 0.629 | CYP2C9 inhibitor | 0.188 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.063 |
CYP2D6 substrate | 0.822 | CYP2E1 substrate | 0.478 |
CYP3A4 inhibitor | 0.123 | CYP3A4 substrate | 0.977 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.783 | CL | 3.91 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.228 | Hepatotoxicity | 0.53 |
Mutagenicity | 0.096 | Rat Oral Acute Toxicity | 0.025 |
FDAMDD | 0.118 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.005 | Eye Corrosion | 0.017 |
Eye Irritation | 0.009 | Respiratory Toxicity | 0.036 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.016 | IGC50 | 3.121 |
LC50FM | 3.577 | LC50DM | 4.838 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.138 | NR-AR-LBD | 0.159 |
NR-AhR | 0.006 | NR-Aromatase | 0.061 |
NR-ER | 0.309 | NR-ER-LBD | 0.46 |
NR-PPAR-gamma | 0.22 | SR-ARE | 0.358 |
SR-ATAD5 | 0.356 | SR-HSE | 0.21 |
SR-MMP | 0.069 | SR-p53 | 0.042 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.